Bahrain - engleză - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

behzad pharmacy - diphenhydramine hydrochloride, menthol - syrup - 7

Bahrain - engleză - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

behzad pharmacy - diphenhydramine hydrochloride - syrup - 14

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

spimaco, saudi arabia - diphenhydramine hydrochloride,menthol - syrup - 140,11 mg,

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

spimaco, saudi arabia - diphenhydramine hydrochloride - syrup - 2.8 mg/ml

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hyclate, quantity: 57.5 mg (equivalent: doxycycline, qty 50 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; quinoline yellow; macrogol 4000 - note: the 50mg tablet is not a paediatric formulation. doxycycline is indicated in the treatment of infections caused by the following microorganisms: mycoplasma pneumoniae: primary atypical pneumonia; rickettsiae: queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus; chlamydia psittaci: psittacosis; calymmatobacterium (donovania) granulomatis: granuloma inguinale; chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.); doxycycline is indicated in the treatment of infections caused by the following gram-negative microorganisms: vibrio species: cholera; brucella species: brucellosis (in conjunction with streptomycin); yersinia pestis: plague; francisella tularensis: tularaemia; bartonella bacilliformis: bartonellosis; bacteroides species. doxycycline is active against both pre-erythrocytic and asexual bloodstages of plasmodium falciparum. the tetracyclines are only partially active against the pre-erythrocytic stages of plasmodium vivax, and protection depends on drug suppression of the blood stages. doxycycline has no activity against the relapsing forms (hypnozoites) of plasmodium vivax. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p.vivax. as there are relatively few locations where p.vivax does not co-exist to some extent with p.falciparum, it is recommended that doxycycline should be used routinely with other agents, eg. chloroquine. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum: syphilis; treponema pertenue: yaws; neisseria gonorrhoeae: gonorrhoea. doxycycline may be a useful adjunct to amoebicides in the treatment of acute intestinal amoebiasis. in the treatment of severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is not the drug of choice in the following: any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxylin should not be used for these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci, (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hyclate, quantity: 115 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; quinoline yellow; macrogol 4000 - doxycycline is indicated in the treatment of infections caused by the following microorganisms: mycoplasma pneumoniae: primary atypical pneumonia; rickettsiae: queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus; chlamydia psittaci: psittacosis; calymmatobacterium (donovania) granulomatis: granuloma inguinale; chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.); doxycycline is indicated in the treatment of infections caused by the following gram-negative microorganisms: vibrio species: cholera; brucella species: brucellosis (in conjunction with streptomycin); yersinia pestis: plague; francisella tularensis: tularaemia; bartonella bacilliformis: bartonellosis; bacteroides species. doxycycline is active against both pre-erythrocytic and asexual bloodstages of plasmodium falciparum. the tetracyclines are only partially active against the pre-erythrocytic stages of plasmodium vivax, and protection depends on drug suppression of the blood stages. doxycycline has no activity against the relapsing forms (hypnozoites) of plasmodium vivax. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p.vivax. as there are relatively few locations where p.vivax does not co-exist to some extent with p.falciparum, it is recommended that doxycycline should be used routinely with other agents, eg. chloroquine. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum: syphilis; treponema pertenue: yaws; neisseria gonorrhoeae: gonorrhoea. doxycycline may be a useful adjunct to amoebicides in the treatment of acute intestinal amoebiasis. in the treatment of severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is not the drug of choice in the following: any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxylin should not be used for these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci, (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hyclate (hydrochloride) -

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novopharm - doxycycline - capsule - 100 mg

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hydrochloride -

Israel - engleză - Ministry of Health

dexcel ltd, israel - doxycycline as hyclate - tablets - doxycycline as hyclate 100 mg - doxycycline - doxycycline has been found clinically effective in the treatment of a variety of infections caused by susceptible strains of gram-positive and gram-negative bacteria and certain other microorganisms.-respiratory tract infections: pneumonia and other lower respiratory tract infections due to susceptible strains of streptococcus pneumoniae, haemophilus influenzae, klebsiella pneumoniae, moraxella catarrhalis and other organisms. mycoplasma pneumonia. treatment of chronic bronchitis, sinusitis.-urinary tract infections: infections caused by susceptible strains of klebsiella species, enterobacter species, escherichia coli, streptococcus faecalis and other organisms.-sexually transmitted diseases: infections due to chlamdyia trachomatis including uncomplicated urethral, endocervical or rectal infections. non-gonococcal urethritis caused by ureaplasma urealiticum (t-mycoplasma). doxylin 100 is also indicated in infections due to calymmatobacterium granulomatis. doxylin is an alternative drug in the treatment of gonorrhoea and syphilis.since doxycycline is a member of the tetracycline series of antibiotics, it may be expected to be useful in the treatment of infections which respond to other tetracyclines, such as:-ophthalmic infections: treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.-rickettsial infections: rocky mountain spotted fever, typhus group, q fever, coxiella endocarditis. -other infections: psittocosis, brucellosis (in combination with streptomycin), cholera, bubonic plague, louse and tick-borne relapsing fever including stage 1 and stage 2 lyme disease, leptospirosis, tularaemia glanders, chloroquine-resistant falciparum malaria and acute intestinal amoebiasis (as an adjunct to amoebicides). infections due to susceptible strains of bacteroides species, and listeria species. -doxylin is an alternative drug in the treatment of leptospirosis, gas gangrene and tetanus. -doxylin is indicated for prophylaxis in the following conditions: scrub typhus, traveller's diarrhoea (enterotoxigenic escherichia coli), leptospirosis, malaria and cholera. -anthrax due to bacillus anthracis, including inhalational anthrax (post exposure): to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis.